Bill > HB3065

This bill modifies the requirements for collaborative practice arrangements between physicians and advanced practice registered nurses (APRNs), which are written agreements outlining how these healthcare professionals will work together. Key changes include allowing APRNs to prescribe certain controlled substances, with specific limitations on Schedule II drugs like hydrocodone and a thirty-day supply limit for buprenorphine for substance use disorder treatment, and permitting APRNs to prescribe Schedule II controlled substances for hospice patients under specific conditions. The bill also updates requirements for the written collaborative practice agreements, mandating details like contact information, office locations, disclosure statements for patients, and the manner of collaboration, including provisions for geographic proximity waivers for rural health clinics, correctional centers, and telehealth use, with a defined review process for such waivers. Additionally, it clarifies that certified registered nurse anesthetists can provide anesthesia services under supervision without a collaborative practice arrangement, though they can still enter into one with limitations on prescribing controlled substances, and it sets a limit of six full-time equivalent APRNs, physician assistants, or assistant physicians a physician can collaborate with, with exceptions for hospital employees and certain public health services. The bill also emphasizes the physician's ultimate authority and the right of both physicians and APRNs to refuse collaboration without penalty, and it introduces a requirement for physicians to report their collaborative practice arrangements to the state board of registration for the healing arts.

https://house.mo.gov/Bill.aspx?bill=HB3065&year=2026&code=R